You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

and cognition (CANTAB)

Showing 1 - 25 of 2,776
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hereditary Spastic Paraplegia, Hereditary, Spastic Paraplegia, Autosomal Dominant Trial in Tübingen (other, behavioral,

Recruiting
  • Hereditary Spastic Paraplegia
  • Hereditary, Spastic Paraplegia, Autosomal Dominant
  • SPRS Score and clinical signs
  • +6 more
  • Tübingen, Germany
    University Hospital Tübingen, Center for Neurology
Aug 18, 2022

Sports ConcUssion Events - Rapid Assessment of Concussion and

Active, not recruiting
  • Concussion, Brain
  • Motor Vehicle Accident
  • Clinical assessment (SCAT5)
  • +5 more
  • Cambridge, Cambridgeshire, United Kingdom
    Mr Stephen Kelleher
Apr 27, 2021

Aspects of Self-harm - Cognition, Imaging and Treatability

Recruiting
  • Self-Harm, Deliberate
  • +3 more
  • Emotional Stop Signal Task
  • +8 more
  • Lund, Skåne, Sweden
    Psykiatri och habilitering, Region Skåne
May 23, 2021

Studying Cognition in SPG4

Completed
  • Cognitive Impairment
  • Hereditary Spastic Paraplegia
  • CANTAB
  • MOCA
  • Tubingen, Germany
    University Hospital Tübingen, Center for Neurology
Aug 26, 2020

Cognitive Impairment, Bipolar Disorder, Depression Trial in Copenhagen (Altitude-like hypoxia (12% O2), Normoxia (20% O2),

Recruiting
  • Cognitive Impairment
  • +2 more
  • Altitude-like hypoxia (12% O2)
  • +3 more
  • Copenhagen, Capital Region Of Copenhagen, Denmark
    Neurocognition and Emotion in Affective Disorders (NEAD) Centre,
Nov 10, 2023

Insomnia Trial (cognitive behavioral therapy for sleep, anxiety, and depression, education about healthy nutrition habits and

Not yet recruiting
  • Insomnia
  • cognitive behavioral therapy for sleep, anxiety, and depression
  • education about healthy nutrition habits and communication in older age
  • (no location specified)
Sep 4, 2023

Cognitive Deficit in Attention, Executive Dysfunction, Emotional Regulation Trial in Ithaca (Maternal Choline Supplementation

Not yet recruiting
  • Cognitive Deficit in Attention
  • +2 more
  • Maternal Choline Supplementation 930 mg/d
  • Maternal Choline Supplementation 480 mg/d
  • Ithaca, New York
    Cornell University, Division of Nutritional Sciences
May 12, 2023

Post-COVID-19 Syndrome Trial in Columbia (CO-OP Procedures, Inactive Control Group)

Not yet recruiting
  • Post-COVID-19 Syndrome
  • CO-OP Procedures
  • Inactive Control Group
  • Columbia, Missouri
    University of Missouri Department of Occupational Therapy
Nov 14, 2023

Mild Cognitive Impairment, Dementia Trial in United States (CST-2032, matching for CST-2032, CST-107, matching for CST-107)

Recruiting
  • Mild Cognitive Impairment
  • Dementia
  • CST-2032, matching placebo for CST-2032, CST-107, matching placebo for CST-107
  • Scottsdale, Arizona
  • +14 more
Jan 4, 2023

Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)

Recruiting
  • Metastatic Prostate Cancer
  • +3 more
  • San Diego, California
  • +11 more
Nov 28, 2022

Bipolar Disorder, Cognitive Impairment, Unipolar Depression Trial in Copenhagen (Erythropoietin, Saline)

Recruiting
  • Bipolar Disorder
  • +2 more
  • Copenhagen, Denmark
    Mental Health Services, Capital Region of Denmark, Copenhagen Un
Apr 7, 2022

Sedentary Lifestyle, Blood Pressure, Arterial Stiffness Trial in Durham (Blueberry Plus Exercise (BB-EX), Blueberry Placebo Plus

Completed
  • Sedentary Lifestyle
  • +3 more
  • Blueberry Plus Exercise (BB-EX)
  • Blueberry Placebo Plus Exercise (P-EX)
  • Durham, North Carolina
    Duke University Medical Center
Jan 19, 2023

Bipolar Disorder Trial in São Paulo (Metacognitive Training, Treatment as Usual)

Recruiting
  • Bipolar Disorder
  • Metacognitive Training
  • Treatment as Usual
  • São Paulo, Brazil
    Institute of Psychiatry, Clinic Hospital University of São Paulo
May 16, 2022

Cancer Trial in Rochester (E-Co)

Not yet recruiting
  • Cancer
  • E-Co
  • Rochester, New York
    University of Rochester
Dec 7, 2022

Cognitive Function Trial in Maastricht (Aronia supplementation, Cellulose supplementation)

Recruiting
  • Cognitive Function
  • Aronia supplementation
  • Cellulose supplementation
  • Maastricht, Netherlands
    Maastricht University
Jan 11, 2023

Alzheimer, Early Onset Trial in Indianapolis (Cognitive Training, Tai Chi- Qi Gong, Brain Games)

Not yet recruiting
  • Alzheimer Disease, Early Onset
  • Cognitive Training
  • +3 more
  • Indianapolis, Indiana
    Indiana University
Oct 5, 2022

Healthy Trial in Copenhagen (Escitalopram 20 mg, Placebo)

Active, not recruiting
  • Healthy
  • Escitalopram 20 mg
  • Placebo
  • Copenhagen, Denmark
    Neurobiology Research Unit
Jul 14, 2022

Memory; Disturbance, Mild Trial in Winnipeg (flaxseed beverage, control beverage)

Recruiting
  • Memory; Disturbance, Mild
  • flaxseed beverage
  • control beverage
  • Winnipeg, Manitoba, Canada
  • +1 more
Jun 29, 2022

Depressive Disorder, MDD Trial in Toronto (Psilocybin, Niacin)

Not yet recruiting
  • Depressive Disorder
  • Major Depressive Disorder
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Oct 2, 2023

22Q11 Deletion Syndrome, tACS Trial (at-home tACS using Starstim-Home tES)

Not yet recruiting
  • 22Q11 Deletion Syndrome
  • tACS
  • at-home tACS using Starstim-Home tES
  • (no location specified)
Dec 15, 2022

Cancer-related Problem/Condition, Cognitive Impairment Trial in Rochester (MAAT-G, Supportive therapy (time and attention

Recruiting
  • Cancer-related Problem/Condition
  • Cognitive Impairment
  • MAAT-G
  • Supportive therapy (time and attention control)
  • Rochester, New York
    University of Rochester
Jan 14, 2022

Mild Cognitive Impairment (MCI), Parkinson Disease (PD) Trial (CST-2032, matching for CST-2032, CST-107)

Withdrawn
  • Mild Cognitive Impairment (MCI)
  • Parkinson Disease (PD)
  • CST-2032, matching placebo for CST-2032, CST-107
  • (no location specified)
Oct 22, 2021

Overweight and Obesity Trial in New Haven (RiduZone (90% OEA), Placebo)

Recruiting
  • Overweight and Obesity
  • RiduZone (90% OEA)
  • Placebo
  • New Haven, Connecticut
    Modern Diet and Physiology Research Lab
Nov 18, 2022

Dysmenorrhea, Endometriosis Trial in Stockholm (Melatonin 10 mg, Placebo, Melatonin 20 mg)

Completed
  • Dysmenorrhea
  • Endometriosis
  • Melatonin 10 mg
  • +2 more
  • Stockholm, Sweden
    Södersjukhuset
Apr 4, 2022

Insomnia, Cognitive Dysfunction, Mild Cognitive Impairment Trial in Charlottesville (SHUTi OASIS, Patient Education)

Not yet recruiting
  • Insomnia
  • +8 more
  • SHUTi OASIS
  • Patient Education
  • Charlottesville, Virginia
    University of Virginia
Sep 29, 2022